Skip to main content

sec filings

Insider trades

Open-market buys and sales that company insiders report to the SEC on .

Side
Planned sales
Role
XFOR

Updated 10/6/2026, 10:27 AM ET.

XFOR

X4 Pharmaceuticals, Inc

Sale$33,658

KIRSKE DAVID

Chief Financial Officer

11,767 shat $2.86Filed Oct 5, 4:03 PM ETFiling
XFOR

X4 Pharmaceuticals, Inc

Sale$109,228

Volpone John

President

24,576 shat $4.44Filed Aug 13, 4:13 PM ETFiling
XFOR

X4 Pharmaceuticals, Inc

Sale$210,829

Craig Adam R

Executive Chairman, Director

47,436 shat $4.44Filed Aug 13, 4:10 PM ETFiling

Read from public SEC filings. Not financial advice.